Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[The effectiveness of tele-rehabilitation for patients with multiple sclerosis during the COVID-19 pandemic in 2020-2021 was evaluated in this study].
Sivertseva SA, Anfilofeva KS, Zotova AV, Kazantsev VA, Belkina AY, Volkova LI, Guseva ME, Boyko AN. Sivertseva SA, et al. Among authors: volkova li. Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(3):75-81. doi: 10.17116/jnevro202412403175. Zh Nevrol Psikhiatr Im S S Korsakova. 2024. PMID: 38529866 Russian.
[Assessment of the efficacy and safety of alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis in Russian population].
Sivertseva SA, Prilenskaya AM, Popova EV, Turova EL, Volkova LI, Smagina IV, Elchaninova EY, Afanas'eva AI, Goncharova ZA, Markova EA, Yarosh NM, Bakhtiiarova KZ, Sherman MA, Boyko AN. Sivertseva SA, et al. Among authors: volkova li. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(9):76-82. doi: 10.17116/jnevro202312309176. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 37796071 Russian.
[Efficacy, tolerability and safety of the treatment with teberif: the results of a 2-year randomized clinical trial of treatment naïve patients with remitting multiple sclerosis, who have not received DMT, after switching from other interferon β-1a].
Boyko AN, Bosenko LP, Vasilovskiy VV, Volkova LI, Zakharova MN, Kotov SV, Lekomtseva EV, Negrich TI, Parshina EV, Patrusheva OP, Prokopenko SV, Sazonov DV, Timchenko LV, Trinitatskiy YV, Khabirov FA, Khavunka MY, Chichanovskaya LV, Sherman MA, Ivanov RA, Lin'kova YN, Stukalina EY, Zinkina-Orikhan AV, Obukhova IG. Boyko AN, et al. Among authors: volkova li. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(2. Vyp. 2):73-85. doi: 10.17116/jnevro20191192273. Zh Nevrol Psikhiatr Im S S Korsakova. 2019. PMID: 31156245 Clinical Trial. Russian.
[Primary progressive multiple sclerosis: current issues of timely diagnosis].
Popova EV, Boyko AN, Barabanova MA, Antipova LN, Bakhtiyarova KZ, Belova AN, Solovieva VS, Belskaya GN, Lukashevich IG, Nikolaeva LI, Volkova LI, Turova EL, Kraeva AV, Goncharova ZA, Malkova NA, Poverennova IE, Sivertseva SA, Zhelnin AV, Trushnikova TN, Khabirov FA, Khaibullin TI. Popova EV, et al. Among authors: volkova li. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10. Vyp. 2):35-40. doi: 10.17116/jnevro201711710235-40. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 29359731 Review. Russian.
[A comparative placebo-controlled clinical study on the efficacy and safety of interferon beta-1a for subcutaneous injections in patients with remitting multiple sclerosis: results of the first year of observations].
Boyko AN, Bosenko LP, Vasilovskiy VV, Volkova LI, Zakharova MN, Kotov SV, Lekomtseva EV, Negrich TI, Parshina EV, Patrusheva OP, Prokopenko SV, Sazonov DV, Timchenko PV, Trinitatskiy YV, Khabirov FA, Khavunka MY, Chichanovskaya LV, Sherman MA, Lin'kova YN, Zinkina-Orikhan AV, Tursunova KB. Boyko AN, et al. Among authors: volkova li. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(2. Vyp. 2):107-113. doi: 10.17116/jnevro201711722107-113. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 28617368 Clinical Trial. Russian.
[Polymorphic variants of the immune response genes as risk factors for primary progressive multiple sclerosis].
Popova EV, Kiselev IS, Boyko AN, Sivertseva SA, Malkova NA, Korobko DS, Spirin NN, Kasatkin DS, Karaeva AV, Turova EL, Spirina NN, Volkova LI, Baulina NM, Bashinskaya VV, Kulakova OG, Favorova OO. Popova EV, et al. Among authors: volkova li. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(2. Vyp. 2):14-21. doi: 10.17116/jnevro20171172214-21. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 28617357 Russian.
[Clinical recommendations on the use of teriflunomide].
Alifirova VM, Bakhtiyarova KZ, Belova AN, Bisaga GN, Boiko AN, Boiko OV, Vlasov YV, Volkova LI, Goncharova ZA, Davydovskaya MV, Zakharova MN, Kotov SV, Lashch NY, Malkova NA, Petrov AM, Popova EV, Sivertseva SA, Sokolova IA, Spirin NN, Stolyarov ID, Streknev AG, Totolyan NA, Khachanova NV, Sherman MI, Shmidt TE, Khabirov FA, Yampol'skaya-Gosteva IA. Alifirova VM, et al. Among authors: volkova li. Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(10 Pt 2):98-104. doi: 10.17116/jnevro201611610298-104. Zh Nevrol Psikhiatr Im S S Korsakova. 2016. PMID: 28139617 Russian. No abstract available.
69 results